Posted by LostBoyinNC1 on July 28, 2002, at 22:05:02
In reply to Menage a trois, posted by BekkaH on July 28, 2002, at 17:50:30
> Many psychopharmacologists are in bed with the greedy pharmaceutical companies, and the FDA is in bed with both of them.
The thing that irritates me is that a lot of pharmaceutical companies are telling psychiatrists that the new atypical anti-psychotics dont cause movement disorders. And that they can routinely put depressives and those with anxiety disorders on atypical anti-psychotics. Thats WRONG. Atypicals cause movement disorders just like the older typicals do.
And some psychiatrists believe the pharmaceutical companies. Another thing thats happening is the pharmaceutical companies are telling Pdocs and even family medicine doctors who treat run of the mill anxiety that they can put patients on atypicals instead of benzos and not risk benzo addiction. Oh...how convenient. So instead of benzo addiction you end up with a nasty case of EPS and have to take Cogentin for a few months. Some doctors would actually rather you develop a mild movement disorder than get hooked on benzos!!
Eli Lilly is trying to get zyprexa FDA approved for non psychotic treatment resistant depression! I dont know if that will make it thru the FDA, but if it does I believe it could be the eventual downfall of Eli Lilly, once all those affective disordered people without psychosis start developing EPS out the wazoo. They will be running to lawyers. The lawyers will love it.
I once had a Duke psychiatrist tell me that zyprexa works more on serotonin than on dopamine. 5HT2A receptor antagonism. But you still get some dopamine blockade with even low dose zyprexa. For some depressives, that small amount of dopamine blockade maybe too much for them to handle physically and they might end up with bad EPS. A schizophrenic could handle it easily, but a depressive I dont know about.
I call it the "Zyprexa numb tongue" syndrome.
poster:LostBoyinNC1
thread:114048
URL: http://www.dr-bob.org/babble/20020725/msgs/114078.html